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Take home message: Multi-national task force provides consensus recommendations for palliative 
care for patients with COVID-19.  
Abstract 
Background: Many people are dying from COVID-19, but consensus guidance on palliative care in 
COVID-19 is lacking. This new life-threatening disease has put healthcare systems under pressure, 
with increased need of palliative care provided to many patients by clinicians with limited prior 
experience in this field. Therefore, we aimed to make consensus recommendations for palliative 
care for patients with COVID-19 using the Convergence of Opinion on Recommendations and 
Evidence (CORE) process. 
Methods: We invited 90 international experts to complete an online survey including stating their 
agreement, or not, with 14 potential recommendations. At least 70% agreement on directionality 
was needed to provide consensus recommendations. If consensus was not achieved on the first 
round, a second round was conducted. 
Results: 68 experts (75.6%) responded in the first round. Most participants were experts in palliative 
care, respiratory medicine or critical care medicine. In the first round, consensus was achieved on 13 
recommendations based upon indirect evidence and clinical experience. In the second round, 58/68 
(85.3%) of the first round experts responded, resulting in consensus also for the 14th 
recommendation. 
Conclusions: This multi-national task force provides consensus recommendations for palliative care 
for patients with COVID-19 concerning: advance care planning; (pharmacological) palliative 
treatment of breathlessness; clinician-patient communication; remote clinician-family 
communication; palliative care involvement in patients with serious COVID-19; spiritual care; 
psychosocial care; and bereavement care. Future studies are needed to generate empirical evidence 
for these recommendations. 
  
INTRODUCTION 
As of June 30, 10.360.882 COVID-19 cases are confirmed with 507.014 deaths due to COVID-19 
recorded globally.[1] However, both the number of confirmed cases and COVID-19 related mortality 
are likely to be under-estimated as not all cases and deaths due to COVID-19 are confirmed or 
recorded.[2] Patients may die at home, in the hospital, or in other facilities. The importance of 
palliative care in this COVID-19 pandemic has been acknowledged.[3, 4] Despite its paramount need, 
providing high-quality palliative care during this pandemic is challenging. Patients may deteriorate 
quickly, healthcare resources be under pressure, isolation is required and family visits are 
restricted.[5] A case series of 101 hospitalised patients with COVID-19 referred for palliative care 
showed that most patients died within three days,[6] and the need for “emergency” palliative care 
in COVID-19 has been suggested.[7] Worries have arisen about limited access to palliative care 
because of high demands worldwide in the pandemic.[3] Despite a number of guidelines and 
resources proposed by professional and other bodies, neither evidence- nor consensus-based 
guidelines about palliative care in COVID-19 are available. In fact, a survey among hospices in Italy 
revealed that healthcare professionals lacked guidance on care for people dying from COVID-19.[8] 
The COVID-19 crisis has been a professionally and personally challenging period for healthcare 
workers. Although the underlying principles of palliative care have not changed, the specific 
challenges of COVID-19 require specific guidance.[4] Therefore, the aim of the current study was to 
develop guidance on palliative care in COVID-19 patients through consensus, pending empirical 
evidence.  
 
METHODS 
We conducted a survey following the Convergence of Opinion on Recommendations and Evidence 
(CORE) process. The CORE process is a consensus-based approach to making clinical 
recommendations, which has been shown to yield recommendations that are concordant with 
recommendations developed using the Institute of Medicine-adherent methodology.[9]  
An ad hoc international task force was assembled, including the European Respiratory Society (ERS) 
key opinion leaders in the field of palliative care and respiratory medicine. Invitations were sent to 
90 experts (in palliative care, respiratory medicine, clinical care and research) identified by the task 
force members. A survey was created using SurveyMonkey software (SurveyMonkey, San Mateo, 
CA), consisting of 14 questions with the aim to provide consensus recommendations for clinical care. 
Each question consisted of three parts. The first part presented the question in a modified PICO 
(Patient, Intervention, Comparator, Outcomes) format. The second part was a multiple-choice 
question where the participant was asked to choose a recommendation for or against a given 
therapy: strong recommendation for; conditional recommendation for; no recommendation for or 
against; conditional recommendation against; or strong recommendation against an intervention. 
(Table 1) The third part was a free text box for comments. Three demographic questions were asked 
about each participant’s country, profession and field of expertise.  
In the survey we used the term ‘serious COVID-19’, defined as COVID-19 that carries a high risk of 
mortality, negatively impacts quality of life and daily function, and/or is burdensome in symptoms, 
treatments, or caregiver stress. This definition was based on the definition of serious illness on 
Pallipedia.[10] 
The survey was administered from June 2 to June 11, 2020. Several reminders were sent. Agreement 
of directionality was tabulated for each multiple-choice question. A priori, we defined that at least 
70% agreement on directionality (agreement or disagreement) was needed to be able to provide 
consensus recommendations.[11] The proportion of respondents per choice per question was 
calculated and expressed as a percentage of the total number of respondents. A second round was 
conducted from June 15 to June 18, 2020 for the question not leading to consensus in the first 
round. Results of the first round were summarised for the second round. Free text comments were 
summarized by DJ and these summaries were checked with the data by KM. 
 
 
RESULTS 
Respondents 
In the first round, 68/90 (75.6%) invited experts participated. Respondents were from 15 countries in 
Europe, North America, and Australia and most were physicians. (Table 2) Two-thirds had a 
background in palliative care and one half in respiratory medicine. The second round was completed 
by 58/68 (85.3%) previous respondents. 
Recommendations 
The 14 recommendations for palliative treatment and care are shown below. For each 
recommendation, a theoretical rationale is provided, followed by the results of the present survey. 
For some recommendations, barriers or concerns for implementation were mentioned. (Table 3) 
1. Advance care planning (ACP, discussions of goals and preferences for future medical 
treatment and care) should be routinely done or reviewed by clinicians with patients and 
their loved ones at diagnosis of serious COVID-19. 
Rationale: ACP enables individuals to define goals and preferences for future medical treatment and 
care, to discuss these goals and preferences with family and healthcare providers, and to record and 
review these preferences if appropriate.[12]. Early ACP discussions at time of hospitalisation are 
suggested to avoid unwanted and burdensome life-sustaining treatments.[13, 14].  
Results: Most of the experts recommended strongly (67.6%) or conditionally (29.4%) that ACP should 
be routinely conducted or reviewed by clinicians with patients and their loved ones, at the time of 
diagnosis of serious COVID-19. (Figure 1A)  
ACP was mentioned as ‘the first critical step to guide treatment for these seriously ill patients’. A few 
experts mentioned that ACP should be offered, but patient wishes should be respected if they 
declined. Some mentioned that whether ACP is offered should be dependent on the presence of 
comorbidities and the likelihood of a poor outcome. The need for, and advantages of, proactive ACP 
before the occurrence of COVID-19, especially in frail older patients, was also mentioned. 
2. ACP should be re-evaluated prior to discharge of recovered COVID-19 patients from hospital. 
Rationale: Life-sustaining treatment preferences are likely to change, for example after a change in 
health status. While some patients are less willing to undergo life-sustaining treatments after a 
decline in functional status, other patients are even more willing to undergo life-sustaining 
treatments.[15] For deliberate decisions concerning life-sustaining treatments, patients need 
information about possible outcomes and likelihood of negative outcomes after treatment.[16] An 
ICU admission for acute respiratory distress syndrome associated with COVID-19 may have lower 
chances of survival than an ICU admission for another illness.[14] So, a preference to forego ICU 
admission in case of COVID-19 might not result in a decision to forego all ICU admissions. Therefore, 
evaluation of ACP before discharge of recovered patients with COVID-19 is warranted. 
Results: Most experts recommended strongly (54.4%) or conditionally (25.0%) that ACP should be re-
evaluated prior to discharge of recovered COVID-19 patients from hospital. (Figure 1B) 
Experts mentioned that if patients recover, the serious illness might have influenced preferences 
regarding life-sustaining treatments. Moreover, patients may be able to more fully participate in 
these discussions than during the acute illness. It was also mentioned that re-evaluation of ACP after 
discharge by the family physician might be preferable. 
3. Patients presenting with serious COVID-19 and distressing breathlessness despite optimal 
treatment of underlying causes should be given low-dose opioids for the palliative treatment 
of breathlessness. 
Rationale: Breathlessness is one of the  most prevalent symptoms in hospitalized patients dying from 
COVID-19.[6, 13, 17, 18] Opioids are widely used in palliative care with an evidence base effect for 
relieving breathlessness.[19] Nevertheless, there are no reported trials in COVID-19. A first case 
series of hospitalized patients with COVID-19 referred for palliative care showed that most patients 
were treated with morphine (median dose 10mg/24h subcutaneously) and some received fentanyl 
(median dose 100 microgram/24h) or alfentanil (median dose 500 microgram/24h).[6] However, 
effectiveness was clinician rated and data were not collected for individual drugs. Another case 
series of 30 hospitalized deceased patients showed that 76.7% of the patients used intravenous 
morphine but, again, effectiveness was not evaluated.[17]  
Results. Most experts recommended strongly (55.9%) or conditionally (27.9%) that patients 
presenting with serious COVID-19 and distressing breathlessness, despite optimal treatment of 
underlying causes, should be given low-dose opioids for the palliative treatment of breathlessness. 
(Figure 1C) 
Experts mentioned the need to treat breathlessness according to current palliative care guidelines, 
including opioids. They mentioned positive experiences of opioids for breathlessness in COVID-19. 
Some experts stated that effectiveness for breathlessness in COVID-19 should be confirmed by 
future studies, but agreed with the recommendation. Conversely, others cited the lack of evidence 
of effectiveness for breathlessness in COVID-19 as a reason to disagree or provide no 
recommendation for or against opioids. Experts stated the need for careful consideration of the 
individual situation, including risk for adverse effects. 
4 Patients presenting with serious COVID-19 and distressing breathlessness despite optimal 
treatment of underlying causes should be given benzodiazepines for the palliative treatment 
of breathlessness 
Rationale. Clinical practice statements mention benzodiazepines as palliative treatment of 
breathlessness.[20] Nevertheless, a Cochrane review showed no evidence for benzodiazepines for 
breathlessness in patients with cancer or COPD.[21] This Cochrane review suggested that 
benzodiazepines could be considered for palliative treatment of breathlessness when non-
pharmacological measures and opioids fail, particularly in patients with distress and anxiety.[21] 
Data on effectiveness for breathlessness in COVID-19 are lacking. 
Results. In the first round, 11.8% of the respondents gave a strong recommendation for 
benzodiazepines for distressing breathlessness and 44.1% gave a conditional recommendation. As 
the predefined 70% threshold for consensus was not reached, the question was asked again in 
second round.  In this round, 5.2% of the respondents gave a strong and 70.7% of the respondents 
provided a conditional recommendation for benzodiazepines for distressing breathlessness. (Figure 
1D)  
A few experts stressed the fact that there is lack of evidence for effect for breathlessness, while 
there is evidence of side-effects. Several experts mentioned that benzodiazepines should be taken in 
consideration if patients were very distressed or anxious, when opioids didn’t have enough effect, 
when opioids were contra-indicated; or in the last days of life.  
5. Patients with serious COVID-19 in palliative care and distressing breathlessness should be 
given oxygen therapy for the palliative treatment of breathlessness when their 
transcutaneous oxygen saturation is below 90%. 
Rationale: Oxygen therapy in patients with COVID-19 and hypoxaemia may help in reducing 
breathlessness in palliative care.[13] Oxygen therapy improves survival in patients with severe 
hypoxemia. The evidence for symptomatic effect on breathlessness is conflicting, but oxygen may 
relieve breathlessness in some patients with hypoxemia. [22]  
Results: A great majority gave a strong (57.4%) or conditional (32.4%) recommendation for oxygen 
therapy for the palliative treatment of breathlessness when their transcutaneous oxygen saturation 
is below 90%. (Figure 1E)  
Free text comments showed some different opinions. Some stressed the importance of correcting 
hypoxaemia, without the primary aim of reducing breathlessness. Several suggested threshold 
oxygen saturations other than 90% such as 85%, 88%, and 92%. Others stressed that supplemental 
oxygen could be started if patients prefer, but discontinued if breathlessness was not reduced. Some 
experts highlighted the insufficient evidence for supplemental oxygen for symptom management at 
this threshold of hypoxemia, whilst others presented anecdotal views that supplemental oxygen was 
often beneficial for breathlessness in patients with COVID-19 and hypoxaemia.  
6. Staff taking care of patients with serious COVID-19 should receive training in optimizing 
clinician–patient communication whilst wearing personal protection equipment (PPE). 
Rationale: Clinician-patient communication is a corner stone of palliative care. Communication with 
patients with COVID-19 can be limited by wearing PPE. Healthcare professionals experience that 
masks hide facial expressions and muffle voices, which restricts the ability to show compassion.[23]   
Results: Almost all experts gave a strong (72.1%) or conditional (19.1%) recommendation for staff 
taking care of patients with serious COVID-19 receiving training in optimizing clinician–patient 
communication whilst wearing PPE. (Figure 1F)  
Experts experienced PPE as a significant and dehumanizing barrier to communication. They felt 
communication while using PPE was a critically important skill that had to be learned. New ways of 
showing empathy are needed along with guidance in these skills. One expert described tools 
developed to improve communication while using PPE, such as flashcards.[24] 
7. Staff taking care of patients with serious COVID-19 should receive training in online clinician–
family communication (while using telephone or video conferencing). 
Rationale: Family meetings for patients with COVID-19 are often held online to preserve PPE.[25] 
Communication and breaking difficult news remotely requires other communication skills in which 
healthcare professionals usually have no previous training. Healthcare professionals rely on in-
person and non-verbal cues to facilitate difficult conversations[26], and may be reluctant to discuss 
sensitive topics during phone or video consultations.[27] Remote communication is more 
challenging for people with low literacy or few digital literacy skills, and people with sight or hearing 
impairment.[27] However, a report from the implementation of palliative care e-family meetings 
with trained clinicians showed the benefits of these meetings, including satisfied family 
members.[28] Key elements of remote communication skills have been published.[29]  
Results: Most experts provided a strong (58.8%) or conditional (29.4%) recommendation for staff 
taking care of patients with serious COVID-19 receiving training in online clinician – family 
communication (while using telephone or video conferencing). (Figure 1G) 
Experts reported the need for a member of the clinical team to communicate remotely with one 
designated family member or loved one daily. Remote communication skills are seen as essential, 
but clinicians are often not familiar with remote palliative care conversations.  
The lack of evidence base for such training as well as practical concerns were mentioned. (Table 3) 
8. Healthcare professionals trained in providing palliative care should be involved in 
hospitalized patients with serious COVID-19 with persistent symptoms and concerns despite 
optimal disease treatment. 
Rationale: Patients with serious COVID-19 with persistent symptoms and concerns despite optimal 
disease treatment need optimal symptom management.[13] It has been suggested that symptom 
burden in dying patients with COVID-19 might be higher than usual in dying patients without COVID-
19,[30] resulting in challenges for staff with no or limited experience in palliative care. Therefore, 
palliative care has an important role for patients with serious COVID-19 and strategies have been 
implemented to provide in-hospital palliative care.[25, 31]  
Results: The majority of experts strongly (63.2%) or conditionally (23.5%) recommended that 
healthcare professionals trained in providing palliative care should be involved in hospitalized 
patients with serious COVID-19 with persistent symptoms and concerns despite optimal disease 
treatment. (Figure 1H)  
Experts reported that expertise in palliative care is needed, with involvement of specialist palliative 
care clinicians varying according to the palliative care skills of the primary clinical team. Specialist 
palliative care could be invited by the primary clinical team for direct patient/family care, advice to 
the primary clinical care team, education and development of guidelines. Benefits of involvement of 
palliative care teams were mentioned such as: multi-disciplinary assessment; ability to address 
aspects of care beyond disease treatment including management of complex symptoms, support of 
family and ACP discussions; and support for other healthcare professionals.  
9. Healthcare professionals trained in providing palliative care should be involved in patients 
with serious COVID-19 with persistent symptoms and concerns despite optimal disease 
treatment treated at home. 
Rationale: Home palliative care services can provide benefits such as better symptom control.[32] 
The Association for Geriatric Palliative Medicine (FGPG) recommends the availability of mobile 
palliative care teams for COVID-19 patients dying at home.[33] Data in COVID-19 are lacking. 
Results: Most experts strongly (51.5%) or conditionally (33.8%) recommended involvement of 
healthcare professionals trained in palliative care provision in patients treated at home with serious 
COVID-19 with persistent symptoms and concerns despite optimal disease treatment. (Figure 1I)  
Several experts mentioned that the need for palliative care involvement for patients at home was 
similar to that described in the hospital setting. Again, the need to involve specialist palliative care 
depends on the skills of the primary clinical team. The added value of involvement of palliative care 
professionals to address psychosocial and spiritual needs in the home setting was mentioned. 
10. Healthcare professionals providing spiritual care (such as chaplains) should be part of the 
treatment team of patients with serious COVID-19 with persistent symptoms and concerns 
despite optimal disease treatment (irrespective of setting, so in the hospital, community or 
long-term care facilities). 
Rationale: Spiritual care is an essential component of palliative care. Indeed, spiritual care supports 
patients and families in facing serious illness and cope with poor or uncertain prognosis.[13] The 
COVID-19 crisis have led to fundamental uncertainty in communities, among patients, caregivers and 
loved ones, and among healthcare professionals. Part of this uncertainty extends beyond healthcare 
science and into our existential notions of life and death. A rapid review recommended to involve 
spiritual care providers in palliative care for patients with COVID-19.[31] Attention is also needed for 
spiritual care needs of those not represented by chaplains or people who are not religious such as 
pastoral care workers.[13] 
Results: Most experts strongly (38.2%) or conditionally (50.0%) recommended that healthcare 
professionals providing spiritual care should be part of the treatment team of patients with serious 
COVID-19 with persistent symptoms and concerns despite optimal disease treatment. (Figure 1J)  
Experts mentioned the need for spiritual or existential care beyond care that clinicians can offer, but 
also that involvement should be dependent on the preference of patient and family. Existential care 
should not be limited to religious care, but include issues in relation to meaning more broadly.  
11. Healthcare professionals providing psychosocial care (such as psychologists and social 
workers) should be part of the treatment team of patients with serious COVID-19 with 
persistent symptoms and concerns despite optimal disease treatment (irrespective of setting, 
so in the hospital, community or long-term care facilities). 
Rationale: Psychological symptoms such as anxiety and agitation are highly prevalent in dying 
patients with COVID-19.[6, 17] Psychosocial interventions in palliative care can relieve emotional and 
existential distress and improve quality of life.[34] Therefore, a rapid review recommended to 
healthcare professionals providing psychosocial care in palliative care for patients with COVID-
19,[31] although data in COVID-19 are not yet available.[35]  
Results: Most experts strongly (52.9%) or conditionally (39.7%) recommended that healthcare 
professionals providing psychosocial care should be part of the treatment team of patients with 
serious COVID-19 with persistent symptoms and concerns despite optimal disease treatment.  
(Figure 1K)  
Comments provided were that the involvement of psychosocial care should depend on needs of 
patients and families and the existing skills within the primary clinical team.  
12. Family members/loved ones should be invited and supported (for example being provided 
with PPE if indicated) to visit in person the dying patient with COVID-19. 
Rationale: Because patients with COVID-19 are treated in isolation, family members/loved ones 
often have no or minimal contact which may aggravate anxiety and other psychological distress. 
Moreover, families may be in quarantine or ill themselves.[7] The inability to say goodbye to family 
before death may increase the risk of complicated grief.[36] When family is allowed to visit, PPE 
might be needed. The value of remote contact between families and dying patients is unknown. 
Some authors caution against virtual contact between families and dying patients with COVID-19 
because it can be experienced as too distressing.[7] Other authors do advise remote contact 
between patients in palliative care and family.[37]  
Results: Almost all experts strongly (80.9%) or conditionally (14.7%) recommend that family 
members/loved ones should be invited and supported to visit the patient dying with COVID-19 in 
person. (Figure 1L)  
Most experts acknowledged the importance of a limited number of closest loved ones being able to 
visit the dying patient for both patients and families.  
13. Family members/loved ones of deceased patients with COVID-19 should be offered 
bereavement support by healthcare professionals trained in palliative care or bereavement 
support. 
Rationale: Family members/loved ones of deceased patients with COVID-19 might be at increased 
risk for complicated grief and post-traumatic stress disorder.[36, 38] Indeed, several risk factors may 
be present such as: a rapid disease trajectory which might have hampered preparation for death; 
less social support caused by social isolation; multiple losses due to COVID-19 in one family; feelings 
of guilt or (self-)blame; and the inability to undertake traditional grieving rituals.[36] Bereavement 
support is seen as a core component of palliative care. Support to families before and after the 
death of a patient can positively influence bereavement outcomes.[38] 
Results: Most gave a strong (66.2%) or conditional (23.5%) recommendation for bereavement 
support being offered to family members/loved ones of deceased patients with COVID-19 by 
healthcare professionals trained in palliative care or bereavement support. (Figure 1M)  
Comments provided included that bereavement risk as well as need for support will vary and some 
people will cope with their usual social or community support.  
14. The international task force suggests that staff caring for patients with serious COVID-19 
should be offered psychological support to cope with their experiences. 
Rationale: During this COVID-19 pandemic, healthcare professionals experience significant 
distress.[39] Healthcare staff caring for patients with serious COVID-19 may experience secondary 
traumatic stress: stress caused by observing suffering and caring for patients dying alone.[36, 39] 
Challenging ethical decisions such as triaging limited resources may result in moral distress. At the 
same time healthcare providers may face personal challenges, such as decisions to isolate 
themselves from personal support systems out of concern for spreading COVID-19.[36, 39] During a 
crisis, attention for self-care may be limited. Adequate supervision and peer support may facilitate 
self-care, which in turn can overcome accumulated stress and grief in healthcare professionals.[36]  
Results: Almost all experts strongly (76.5%) or conditionally (20.6%) recommended that staff caring 
for patients with serious COVID-19 should be offered psychological support to cope with their 
experiences. (Figure 1N) Comments provided were that healthcare staff should have access to a 
range of support dependent on their needs. Debriefs within teams were mentioned as a possibility.  
 
DISCUSSION 
This survey provides 14 consensus-based recommendations for palliative care in patients with 
COVID-19 in the hospital, at home or in other care facilities. Consensus was reached by international 
experts in different relevant fields, including but not limited to palliative care and respiratory 
medicine. Given the recent genesis of COVID-19, recommendations are based upon indirect 
evidence and clinical experience on: ACP; palliative treatment of breathlessness; clinician-patient 
communication; remote clinician-family communication; palliative care involvement in patients with 
serious COVID-19; spiritual care; psychosocial care; bereavement care; and support for healthcare 
professionals. In the absence of evidence-based guidelines, these findings provide consensus 
guidance for palliative care in COVID-19. The paramount role of palliative care in this pandemic[3, 4] 
is supported, but also points to specific challenges and unanswered questions.  
ACP was seen as ‘the first critical step to guide treatment for these seriously ill patients’, but the 
often rapid disease trajectory, as well as physical absence of family or loved ones were specific 
challenges to having these ACP conversations. So, preferably, ACP is initiated much earlier, especially 
in the elderly, chronically ill patients or people with multiple co-morbidities, to prepare patients and 
family for the moment when decisions concerning treatment of COVID-19 should be made. Future 
data concerning long-term outcomes of serious COVID-19 are needed to support the process of ACP. 
Moreover, future studies should explore how to conduct optimal ACP in challenging circumstances 
like an admission for serious COVID-19. 
Palliative treatment of breathlessness seems paramount in COVID-19. Currently, we rely on the 
commonly known palliative treatment options for breathlessness due to other causes, like opioids, 
supplemental oxygen in hypoxemic patients, and benzodiazepines if other treatments fail and 
breathlessness is associated with anxiety. Nevertheless, evidence for effectiveness, adverse effects 
and optimal dosage regimes for opioids and benzodiazepines in COVID-19 are absent. Other physical 
and psychological symptoms also frequently reported by patients with serious COVID-19[6, 17, 18] 
were not included in the present study. Future studies should explore palliative interventions for 
breathlessness and other symptoms in COVID-19. 
To overcome communication barriers in COVID-19, including the need to wear PPE and physical 
absence of families and loved ones, healthcare professionals need new skills and experience. 
Fortunately, tools and trainings are being developed rapidly to facilitate communication with 
patients with COVID-19 and their loved ones.[24, 28, 29, 40] More experience as well as studies 
exploring effects of tools and training are needed to optimally support communication skills in 
palliative care for patients with COVID-19 and their loved ones. 
This study supports the value of involvement of healthcare professionals trained in providing 
palliative care in patients with serious COVID-19 with persistent symptoms and concerns despite 
optimal disease treatment in the hospital and at home. Limited availability of palliative care 
specialists was mentioned as concern. Nevertheless, not all patients may need to be seen by 
specialist palliative care clinicians, as was also stated by several respondents. Indeed, non-palliative 
care specialists can be supported to adopt palliative care strategies, for example through training or 
consultation.[40]  
Methodological considerations 
These recommendations were developed following the CORE methodology, which has been shown 
to result in recommendations concordant with recommendations developed using the Institute of 
Medicine-adherent methodology.[9] Nevertheless, several limitations need to be acknowledged. 
First, although we were able to include experts from 15 countries, we had no respondents from 
Africa or Asia but experts from some countries like Denmark, Portugal and the Netherlands were 
overrepresented. Second, most respondents were physicians; only two nurses and seven allied 
healthcare professionals participated. Relevant fields of expertise, like family medicine, internal 
medicine, geriatrics and clinical pharmacology were underrepresented. The wording of questions 
was unclear to some participants. For example, ‘healthcare professionals trained in providing 
palliative care’ were interpreted by some respondents as specialist palliative care professionals, and 
by other respondents also including healthcare professionals with general training in palliative care. 
Further, defining the population of patients with COVID-19 in need for palliative care was 
challenging for the author group. We have chosen the Palliapedia definition of serious disease[10], 
but other definitions would have been possible. Nevertheless, this definition did not result in 
comments from participating experts. Finally, we had to limit the survey to 14 possible 
recommendations. Some aspects concerning palliative care in COVID-19, such as management of 
agitation, remain unexplored. 
 
Conclusions 
This multinational task force provides consensus recommendations for palliative care for patients 
with COVID-19 concerning: ACP; palliative treatment of breathlessness; clinician-patient 
communication; remote clinician-family communication; palliative care involvement in patients with 
serious COVID-19; spiritual care; psychosocial care; bereavement care; and support for healthcare 
professionals. The fact that 13 out of 14 questions achieved recommendations above 70% in the first 
round shows that there is a need to consider palliative care in the treatment of COVID-19 or similar 
diseases. Future studies are needed to provide empirical evidence for these recommendations. 
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DISCLAIMER 
The goal of consensus guidance is to standardize care, thereby improving outcomes and facilitating 
research. The suggestions in this document do not constitute official positions of the European 
Respiratory Society, or the institutions of the task force members. They should not be considered 
mandates as no suggestion can incorporate all potential clinical circumstances. The suggestions are 
consensus guidance that should be reevaluated as evidence accumulates. 
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Legend figure 1 
Experts’ responses to the 14 questions.  
++ = Strong recommendation for…; + = Conditional recommendation for…; +/- = No recommendation 
for or against; - = Conditional recommendation against…; -- = Strong recommendation against…; * = 
results from the second round. 
 
  
Table 1. Definitions of recommendations 
Strong recommendation for the intervention Should be chosen when experts were certain 
that the desirable consequences outweigh the 
undesirable consequences (or the converse for 
recommendation against). A strong 
recommendation is one that most well 
informed patients would follow.  
A conditional recommendation for an 
intervention 
Should be chosen when experts were uncertain 
that the desirable consequences of the 
intervention outweigh the undesirable 
consequences (or the converse, for 
recommendation against). A conditional 
recommendation indicates that well-informed 
patients may make different choices regarding 
whether to have or not have the intervention. 
 
 
 
 
  
Table 2. Characteristics of respondents 
  n (%) 
Country  Australia 2 (2.9%)  
 Austria 1 (1.5%) 
 Belgium 3 (4.4%) 
 Canada 1 (1.5%) 
 Denmark 14 (20.6%) 
 Germany 3 (4.4.%) 
 Ireland 1 (1.5%) 
 Italy 3 (4.4%) 
 The Netherlands 9 (13.2%) 
 Poland 1 (1.5%) 
 Portugal 9 (13.2%) 
 Sweden 5 (7.4%) 
 Switzerland 2 (2.9%) 
 UK 6 (8.8%) 
 USA 6 (8.8%) 
Profession* Physician 50 (73.5%) 
 Nurse 2 (2.9%) 
 Allied healthcare professional  7 (10.3%) 
 Researcher 16 (23.5%) 
Expertise* Palliative care 46 (67.6%) 
 Respiratory medicine 34 (50.0%) 
 Critical care medicine 9 (13.2%) 
 Geriatrics 3 (4.4%) 
 Family medicine 3 (4.4%) 
 Internal medicine 4 (5.9%) 
 Other 6 (8.8%) 
n=68; *respondents could report >1 profession and/or expertise. 
 
 
  
Table 3. Experts’ reported barriers or concerns towards implementation of recommendations 
 Recommendation Barriers / concerns 
1 ACP should be routinely done or reviewed by 
clinicians with patients and their loved ones at 
diagnosis of serious COVID-19. 
 
 The rapidly evolving disease resulting in 
lack of clarity on the patient's condition to 
allow for a long-term plan 
 The often rapid trajectory towards death 
 Patients being too ill to participate in ACP 
 Patients experiencing too much anxiety to 
participate in ACP conversations 
 Family not being physically present 
6 Staff taking care of patients with serious COVID-
19 should receive training in optimizing clinician–
patient communication whilst wearing PPE 
 Practical concerns to implement a training 
during pandemic 
7 Staff taking care of patients with serious COVID-
19 should receive training in online clinician–
family communication (while using telephone or 
video conferencing). 
 Practical concerns to implement a training 
during pandemic 
 
8 Healthcare professionals trained in providing 
palliative care should be involved in hospitalized 
patients with serious COVID-19 with persistent 
symptoms and concerns despite optimal disease 
treatment. 
 Practical concerns  
 Resource limitations, including limited 
availability of palliative care specialists 
9 Healthcare professionals trained in providing 
palliative care should be involved in patients with 
serious COVID-19 with persistent symptoms and 
concerns despite optimal disease treatment 
treated at home. 
 Limited availability of PPE 
 Limited resources available for patients at 
home or in care homes, including limited 
availability of palliative care specialists 
 Risk of transmission of COVID-19 
10 Healthcare professionals providing spiritual care 
(such as chaplains) should be part of the 
treatment team of patients with serious COVID-
19 with persistent symptoms and concerns 
despite optimal disease treatment (irrespective 
of setting, so in the hospital, community or long-
term care facilities). 
 Limited availability of PPE 
 Limited availability of spiritual / existential 
care providers 
 Patients being too breathless to talk.  
11 Healthcare professionals providing psychosocial 
care (such as psychologists and social workers) 
should be part of the treatment team of patients 
with serious COVID-19 with persistent symptoms 
and concerns despite optimal disease treatment 
(irrespective of setting, so in the hospital, 
community or long-term care facilities). 
 Limited availability of PPE 
 Limited availability of psychosocial 
healthcare professionals 
 Risk of transmission of COVID-19 to 
psychosocial healthcare professionals  
 
12 Family members/loved ones should be invited 
and supported (for example being provided with 
PPE if indicated) to visit in person the dying 
patient with COVID-19. 
 
 Limited availability of PPE; 
 Visits being a source of distress for 
families and staff 
 Risk of transmission of COVID-19 to 
visitors 
 Lack of time between diagnosing dying 
and actual death 
13 Family members/loved ones of deceased patients 
with COVID-19 should be offered bereavement 
support by healthcare professionals trained in 
palliative care or bereavement support 
 Limited availability of bereavement 
support 
Abbreviations: ACP= Advance Care planning; PPE= personal protection equipment. 
 
 
 
 
